Literature DB >> 1235062

Carcinogenic effects of niridazole.

H K Urman, O Bulay, D B Clayson, P Shubik.   

Abstract

Swiss mice received chronic treatment with the schistosomacide, niridazole, at 3 dose levels. Tumors were found in several organs, including stomach, lung, manary gland, ovary and bladder. Niridazole is, without doubt, carcinogenic to mice.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1235062     DOI: 10.1016/s0304-3835(75)95362-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540).

Authors:  E Bueding; R Batzinger; G Petterson
Journal:  Experientia       Date:  1976-05-15

2.  Multicentre trials of praziquantel in human schistosomiasis: design and techniques.

Authors:  A Davis; D H Wegner
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

3.  Treatment of schistosomiasis.

Authors:  G Webbe
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Comparison of the Ames assay and the induction of sister chromatid exchanges: results with ten pharmaceuticals and five selected agents.

Authors:  E K Shubber; D Jacobson-Kram; J R Williams
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

5.  Mutagenicity studies with praziquantel, a new anthelmintic drug: tissue-, host-, and urine-mediated mutagenicity assays.

Authors:  J Obermeier; H Frohberg
Journal:  Arch Toxicol       Date:  1977-09-28       Impact factor: 5.153

6.  Urinary schistosomiasis in Saudi Arabia.

Authors:  D M Wallace
Journal:  Ann R Coll Surg Engl       Date:  1979-07       Impact factor: 1.891

7.  PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?

Authors:  Raphael Taiwo Aruleba; Tayo Alex Adekiya; Babatunji Emmanuel Oyinloye; Priscilla Masamba; Londiwe Simphiwe Mbatha; Ashley Pretorius; Abidemi Paul Kappo
Journal:  Infect Disord Drug Targets       Date:  2019

Review 8.  A Review of Nanotechnology for Targeted Anti-schistosomal Therapy.

Authors:  Tayo Alex Adekiya; Pierre P D Kondiah; Yahya E Choonara; Pradeep Kumar; Viness Pillay
Journal:  Front Bioeng Biotechnol       Date:  2020-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.